First Wave BioPharma
Why Robinhood?
You can watch FWBI and buy or sell other stocks, ETFs, and their options commission-free!About FWBI
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
FWBI Key Statistics
Stock Snapshot
With a market cap of 3.43M, First Wave BioPharma(FWBI) trades at $2.16. The stock has a price-to-earnings ratio of -0.44.
On 2026-02-01, First Wave BioPharma(FWBI) stock opened at —, reached a high of —, and a low of —.
First Wave BioPharma(FWBI) shares are trading with a volume of 0, against a daily average of 204.95K.
During the past year, First Wave BioPharma(FWBI) stock moved between $0.97 at its lowest and $5.84 at its peak.
During the past year, First Wave BioPharma(FWBI) stock moved between $0.97 at its lowest and $5.84 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.